Jack Hobaugh Elected to Blood Cancer United Colorado’s Board of Trustees
Jack Hobaugh, a shareholder in Brownstein Hyatt Farber Schreck’s Corporate and Business Department, has been elected to the Colorado chapter board of trustees for Blood Cancer United.
Blood Cancer United—formerly known as the Leukemia & Lymphoma Society—is dedicated to curing blood cancers and improving the quality of life for patients and their families. Hobaugh has supported the organization since 2023, regularly participating in its annual Light the Night event with Brownstein’s team.
During his two-year term, Hobaugh will collaborate with Blood Cancer United Colorado’s executive director and staff to provide guidance, thought leadership and collaborative action that drives revenue, community building, advocacy and awareness of the organization’s mission.
As a blood cancer survivor, Hobaugh’s commitment to the cause is deeply personal.
“Serving on this board is meaningful for many members,” Hobaugh said. “Most have been touched by blood cancer—whether through the loss of a loved one, caring for someone battling the disease or surviving it themselves. I am no different.”
For more information, visit https://bloodcancerunited.org/.
Recent Insights
Read MoreColorado AI law focuses on governance, not gadgets
Client Alert | March 23, 2026Fifth Circuit Refuses to Stay District Court Decision Voiding New HSR Rules
Client Alert | March 20, 2026AI Governance Takes Shape: Breaking Down Washington’s Latest AI Frameworks
Presentation | March 18, 2026State of Play
Client Alert | March 17, 2026FTC Seeks Comments on Rental Housing Fees and Negative Option Marketing
Client Alert | March 17, 2026Trump Issues Executive Orders on Mortgage Credit, Housing Construction
You have chosen to send an email to Brownstein Hyatt Farber Schreck or one of its lawyers. The sending and receipt of this email and the information in it does not in itself create and attorney-client relationship between us.
If you are not already a client, you should not provide us with information that you wish to have treated as privileged or confidential without first speaking to one of our lawyers.
If you provide information before we confirm that you are a client and that we are willing and able to represent you, we may not be required to treat that information as privileged, confidential, or protected information, and we may be able to represent a party adverse to you and even to use the information you submit to us against you.
I have read this and want to send an email.